Abstract
epsis is a major challenge of medical practice, with mortality of up to 70% in severe cases. In recent decades, great efforts have been made in target-specific therapies, focusing on pro-inflammatory cytokines and coagulation activation as the main therapeutic targets. Unfortunately the positive results in animal models have not translated into significant changes in the treatment of seps…